Role of Pyroptosis in Intervertebral Disc Degeneration and Its Therapeutic Implications
- PMID: 36551232
- PMCID: PMC9775394
- DOI: 10.3390/biom12121804
Role of Pyroptosis in Intervertebral Disc Degeneration and Its Therapeutic Implications
Abstract
Intervertebral disc degeneration (IDD), a progressive and multifactorial pathological process, is predominantly associated with low back pain and permanent disability. Pyroptosis is a type of lytic programmed cell death triggered by the activation of inflammasomes and caspases. Unlike apoptosis, pyroptosis is characterized by the rupture of the plasma membrane and the release of inflammatory mediators, accelerating the destruction of the extracellular matrix (ECM). Recent studies have shown that pyrin domain-containing 3 (NLRP3) inflammasome-mediated pyroptosis in nucleus pulposus (NP) cells is activated in the progression of IDD. Furthermore, targeting pyroptosis in IDD demonstrates the excellent capacity of ECM remodeling and its anti-inflammatory properties, suggesting that pyroptosis is involved in the IDD process. In this review, we briefly summarize the molecular mechanism of pyroptosis and the pathogenesis of IDD. We also focus on the role of pyroptosis in the pathological progress of IDD and its targeted therapeutic application.
Keywords: NLRP3 inflammasome; intervertebral disc degeneration; nucleus pulposus; pyroptosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Therapeutic potential of targeting the IRF2/POSTN/Notch1 axis in nucleus pulposus cells for intervertebral disc degeneration.J Neuroinflammation. 2025 Jan 22;22(1):13. doi: 10.1186/s12974-025-03335-4. J Neuroinflammation. 2025. PMID: 39844302 Free PMC article.
-
SOX4 accelerates intervertebral disc degeneration via EZH2/NRF2 pathway in response to mitochondrial ROS-dependent NLRP3 inflammasome activation in nucleus pulposus cells.J Transl Med. 2025 Apr 3;23(1):395. doi: 10.1186/s12967-024-05913-1. J Transl Med. 2025. PMID: 40181390 Free PMC article.
-
Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis.Inflammopharmacology. 2023 Feb;31(1):369-384. doi: 10.1007/s10787-022-01098-5. Epub 2022 Nov 19. Inflammopharmacology. 2023. PMID: 36401729 Free PMC article.
-
Roles of pyroptosis in intervertebral disc degeneration.Pathol Res Pract. 2023 Aug;248:154685. doi: 10.1016/j.prp.2023.154685. Epub 2023 Jul 16. Pathol Res Pract. 2023. PMID: 37494803 Review.
-
Roles of NLRP3 inflammasome in intervertebral disc degeneration.Osteoarthritis Cartilage. 2021 Jun;29(6):793-801. doi: 10.1016/j.joca.2021.02.204. Epub 2021 Feb 18. Osteoarthritis Cartilage. 2021. PMID: 33609693 Review.
Cited by
-
The Survival of Human Intervertebral Disc Nucleus Pulposus Cells under Oxidative Stress Relies on the Autophagy Triggered by Delphinidin.Antioxidants (Basel). 2024 Jun 23;13(7):759. doi: 10.3390/antiox13070759. Antioxidants (Basel). 2024. PMID: 39061828 Free PMC article.
-
Transcriptome Data Combined With Mendelian Randomization Analysis Identifies Key Genes Associated With Mitochondria and Programmed Cell Death in Intervertebral Disc Degeneration.JOR Spine. 2025 Mar 24;8(1):e70057. doi: 10.1002/jsp2.70057. eCollection 2025 Mar. JOR Spine. 2025. PMID: 40130183 Free PMC article.
-
Role of Autophagy and Pyroptosis in Intervertebral Disc Degeneration.J Inflamm Res. 2024 Jan 6;17:91-100. doi: 10.2147/JIR.S434896. eCollection 2024. J Inflamm Res. 2024. PMID: 38204989 Free PMC article. Review.
-
Single-cell sequencing reveals cellular heterogeneity of nucleus pulposus in intervertebral disc degeneration.Sci Rep. 2024 Nov 8;14(1):27245. doi: 10.1038/s41598-024-78675-x. Sci Rep. 2024. PMID: 39516278 Free PMC article.
-
Therapeutic potential of targeting the IRF2/POSTN/Notch1 axis in nucleus pulposus cells for intervertebral disc degeneration.J Neuroinflammation. 2025 Jan 22;22(1):13. doi: 10.1186/s12974-025-03335-4. J Neuroinflammation. 2025. PMID: 39844302 Free PMC article.
References
-
- Disease G.B.D., Injury I., Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–1259. doi: 10.1016/S0140-6736(17)32154-2. - DOI - PMC - PubMed
-
- Cheung K.M., Karppinen J., Chan D., Ho D.W., Song Y.Q., Sham P., Cheah K.S., Leong J.C., Luk K.D. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine. 2009;34:934–940. doi: 10.1097/BRS.0b013e3181a01b3f. - DOI - PubMed
-
- de Schepper E.I., Damen J., van Meurs J.B., Ginai A.Z., Popham M., Hofman A., Koes B.W., Bierma-Zeinstra S.M. The association between lumbar disc degeneration and low back pain: The influence of age, gender, and individual radiographic features. Spine. 2010;35:531–536. doi: 10.1097/BRS.0b013e3181aa5b33. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous